Compound for inhibiting type 5 phosphodiesterase and preparation method thereof

Details for Australian Patent Application No. 2010356747 (hide)

Owner Suzhou Maidixian Pharmaceutical Inc.

Inventors Zhang, Nan; Zhong, Rong

Agent Watermark

Pub. Number AU-A-2010356747

PCT Pub. Number WO2012/000212

Priority 201010221658.7 02.07.10 CN

Filing date 30 July 2010

Wipo publication date 5 January 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2012/000212 Priority application(s): WO2012/000212

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010356762-Method of p2p video communication implemented on web page

2010356716-Drawer assembly and refrigerator with it